Drug Markets/Tiagabine Hydrochloride

Tiagabine Hydrochloride

10 NDCs across 3 manufacturers|10 Generic,0 Brand

Tiagabine Hydrochloride is used to treat bipolar disorder and partial epilepsies, per the National Library of Medicine's MED-RT classification.

▸ More about this market

The brand product was first FDA-approved on Sep 30, 1997, and the first generic was approved Nov 4, 2011. FDA's Orange Book lists 8 AB-rated (therapeutically equivalent) products for this ingredient.

Tiagabine Hydrochloride is available as 10 NDCs from 3 manufacturers (10 generic, 0 brand), with NADAC prices from $1.92 to $6.64 per EAthe most expensive product costs about 3.5× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

10

10G / 0B

Manufacturers

3

competing in market

Price Spread

$1.92 – $6.64

per EA

7d Activity

226 flat

avg +3.5% WoW · of 10 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Drug Portfolio

10 NDCs total, 10 shown

Frequently Asked Questions

What is Tiagabine Hydrochloride used to treat?

Tiagabine Hydrochloride is used to treat bipolar disorder and partial epilepsies, per the National Library of Medicine's MED-RT classification.

When did Tiagabine Hydrochloride become available as a generic?

FDA approved the first generic Tiagabine Hydrochloride (ANDA) on Nov 4, 2011. The Orange Book currently lists 8 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.

How many Tiagabine Hydrochloride products are on the market?

The Tiagabine Hydrochloride drug market contains 10 NDCs from 3 manufacturers — 10 generic and 0 brand products.

What is the price range for Tiagabine Hydrochloride?

NADAC reference prices for Tiagabine Hydrochloride range from $1.9228 to $6.6399 per EA — the most expensive product costs about 3.5× the cheapest.

Which manufacturers make Tiagabine Hydrochloride?

3 manufacturers list Tiagabine Hydrochloride in NADAC. Ranked by number of NDCs, the largest are Novadoz Pharmaceuticals LLC (4), Teva Pharmaceuticals USA Inc. (4), Sun Pharmaceutical Industries Inc. (2).

How has the price of Tiagabine Hydrochloride changed recently?

Over the past 7 days, 2 Tiagabine Hydrochloride NDCs rose and 2 fell, with a market-wide average change of +3.5%.